---
title: "CF PharmTech (2652) stock listing, news and investor profile"
url: "https://aibio.space/companies/cf-pharmtech/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "CF PharmTech, Inc. (HKEX: 2652), China. The directory classifies it as Pharmaceuticals: Major."
---

2652 CF PharmTech, Inc. HKEX · China

# CF PharmTech (2652) news

CF PharmTech, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2652, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest CF PharmTech news

We have not published a story on CF PharmTech yet. When there is news, it will appear here.

## CF PharmTech at a glance

- **Ticker**: 2652

- **Listing**: HKEX

- **Country**: China

### Related companies

- [Enwei Pharmaceutical Co.](https://aibio.space/companies/enwei-pharmaceutical/) SZSE: 301331
- [Yili Chuanning Biotechnology Co.](https://aibio.space/companies/yili-chuanning-biotechnology/) SZSE: 301301
- [ApicHope Pharmaceutical Group Co.](https://aibio.space/companies/apichope-pharmaceutical/) SZSE: 300723
- [Zhejiang Hisun Pharmaceutical Co.](https://aibio.space/companies/zhejiang-hisun-pharmaceutical/) SSE: 600267
- [Zhuhai Rundu Pharmaceutical Co.](https://aibio.space/companies/zhuhai-rundu-pharmaceutical/) SZSE: 002923
- [Fusen Pharmaceutical Co.](https://aibio.space/companies/fusen-pharmaceutical/) HKEX: 1652
- [Shanghai Jiaoda Onlly Co.](https://aibio.space/companies/shanghai-jiaoda-onlly/) SSE: 600530
- [Zhejiang Yatai Pharmaceutical Co.](https://aibio.space/companies/zhejiang-yatai-pharmaceutical/) SZSE: 002370

### Also on HKEX

- [HUTCHMED (China)](https://aibio.space/companies/hutchmed-china/) 13
- [Luye Pharma Group](https://aibio.space/companies/luye-pharma/) 2186
- [Duality Biotherapeutics](https://aibio.space/companies/duality-biotherapeutics/) 9606
- [Hygeia Healthcare Holdings Co.](https://aibio.space/companies/hygeia-healthcare/) 6078
- [Lepu Biopharma Co.](https://aibio.space/companies/lepu-biopharma/) 2157
- [HBM Holdings](https://aibio.space/companies/hbm/) 2142

## Questions about CF PharmTech

What is the ticker symbol of CF PharmTech?

CF PharmTech, Inc. trades under the ticker 2652 on HKEX.

Where is CF PharmTech listed?

CF PharmTech, Inc. is listed on HKEX.

Which country or territory is CF PharmTech listed under?

Our directory records CF PharmTech, Inc. under China.

What does CF PharmTech do?

Our directory classifies CF PharmTech, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of CF PharmTech?

The ISIN recorded for CF PharmTech, Inc. is CNE1000074R9.

Does aibio.space cover CF PharmTech?

aibio.space lists CF PharmTech, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to CF PharmTech?

Companies in our directory listed in the same country and business area as CF PharmTech: Enwei Pharmaceutical Co., Yili Chuanning Biotechnology Co., ApicHope Pharmaceutical Group Co., Zhejiang Hisun Pharmaceutical Co., Zhuhai Rundu Pharmaceutical Co., Fusen Pharmaceutical Co..

## Investor discussion: CF PharmTech

Members talk about CF PharmTech (2652). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at CF PharmTech, newest first. Each line links the filing it comes from.

1. 2026-08-06 Financings Share or debt issue: COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0806/2026080601859.pdf)
2. 2026-07-30 Financings Share or debt issue: PLACING OF NEW H SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0731/2026073100049.pdf)
3. 2026-06-22 Listings Share consolidation: CHANGE IN BOARD LOT SIZE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0622/2026062201657.pdf)
4. 2026-06-02 Financings Share or debt issue: (1) AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR 2025; (2) 2025 ANNUAL REPORT; (3) ELECTION OF THE FOURTH SESSION OF THE BOARD; (4) ELECTION OF THE FOURTH SESSION OF THE SUPERVISORY COMMITTEE; (5) RE-APPOINTMENT OF AUDITOR FOR 2026; (6) PROPOSED AMENDMENTS TO THE H SHARE AWARD SCHEME; (7) GENERAL MANDATE TO ISSUE H SHARES; (8) SHARE REPURCHASE MANDATE TO REPURCHASE H SHARES; AND (9) NOTICE OF ANNUAL GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060202928.pdf)
5. 2025-11-26 Financings Share or debt issue: PROPOSED SHARE REPURCHASE MANDATE PROPOSED ADOPTION OF H SHARE AWARD SCHEME PROPOSED AUTHORIZATION TO THE BOARD AND/OR AUTHORIZED PERSON TO HANDLE MATTERS RELATING TO THE H SHARE AWARD SCHEME AND NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1126/2025112600883.pdf)
6. 2025-09-25 Financings Share or debt issue: GLOBAL OFFERING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0926/2025092600041.pdf)

## Press releases

Headlines of CF PharmTech's own announcements, newest first. Each opens the full release on the newswire that carried it.

1. 2026-10-05 HKEXnews [VOLUNTARY ANNOUNCEMENT VOLUNTARY EXTENSION OF LOCK-UP PERIOD FOR SHARES HELD BY CORE MANAGEMENT BY SIX MONTHS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1005/2026100502243.pdf)
2. 2026-09-21 HKEXnews [VOLUNTARY ANNOUNCEMENT ICF004 COMPLETES ENROLMENT AND DOSING OF FIRST HEALTHY VOLUNTEER IN PHASE I CLINICAL TRIAL](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0921/2026092101798.pdf)
3. 2026-08-31 HKEXnews [INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0831/2026083102345.pdf)
4. 2026-08-28 HKEXnews [Articles of Association](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0828/2026082803374.pdf)
5. 2026-08-24 HKEXnews [VOLUNTARY ANNOUNCEMENT EXPANSION OF INDICATIONS OF ICF001 FOLLOWING RECEIPT OF IMPLIED CLINICAL TRIAL APPROVALS FROM THE NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0824/2026082401255.pdf)
6. 2026-08-06 HKEXnews [COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE AND AMENDMENTS TO THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0806/2026080601859.pdf)
7. 2026-07-30 HKEXnews [PLACING OF NEW H SHARES UNDER GENERAL MANDATE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0731/2026073100049.pdf)
8. 2026-06-26 HKEXnews [POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 26, 2026; ELECTION OF THE FOURTH SESSION OF THE BOARD; AND ELECTION OF THE FOURTH SESSION OF THE SUPERVISORY COMMITTEE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062602565.pdf)
9. 2026-06-22 HKEXnews [CHANGE IN BOARD LOT SIZE](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0622/2026062201657.pdf)
10. 2026-06-04 HKEXnews [VOLUNTARY ANNOUNCEMENT INHALATION FORMULATION PRODUCTION BASE PASSED GMP INSPECTION IN A PIC/S MEMBER COUNTRY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0604/2026060402735.pdf)
11. 2026-06-02 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060202968.pdf)
12. 2026-06-02 HKEXnews [(1) AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR 2025; (2) 2025 ANNUAL REPORT; (3) ELECTION OF THE FOURTH SESSION OF THE BOARD; (4) ELECTION OF THE FOURTH SESSION OF THE SUPERVISORY COMMITTEE; (5) RE-APPOINTMENT OF AUDITOR FOR 2026; (6) PROPOSED AMENDMENTS TO THE H SHARE AWARD SCHEME; (7) GENERAL MANDATE TO ISSUE H SHARES; (8) SHARE REPURCHASE MANDATE TO REPURCHASE H SHARES; AND (9) NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060202928.pdf)
13. 2026-06-01 HKEXnews [VOLUNTARY ANNOUNCEMENT IND APPROVAL OF ICF004 AS A CLASS 1 NEW DRUG BY THE NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0601/2026060100043.pdf)
14. 2026-05-29 HKEXnews [RESIGNATION OF A NON-EXECUTIVE DIRECTOR AND A SUPERVISOR; AND PROPOSED APPOINTMENT OF AN EXECUTIVE DIRECTOR AND A SUPERVISOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0529/2026052902964.pdf)
15. 2026-05-28 HKEXnews [VOLUNTARY ANNOUNCEMENT SUBMISSION OF MARKETING AUTHORIZATION APPLICATION FOR CF017 IN A SOUTHEAST ASIAN MARKET](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052800189.pdf)
16. 2026-05-26 HKEXnews [VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION FOR TIOTROPIUM BROMIDE INHALATION POWDER BY THE NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0526/2026052600125.pdf)
17. 2026-03-30 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2025](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033000446.pdf)
18. 2026-03-23 HKEXnews [VOLUNTARY ANNOUNCEMENT STRATEGIC COOPERATION WITH JD HEALTH](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0323/2026032300119.pdf)
19. 2026-03-20 HKEXnews [INSIDE INFORMATION PROFIT WARNING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0320/2026032001828.pdf)
20. 2026-03-13 HKEXnews [VOLUNTARY ANNOUNCEMENT ACCEPTANCE OF IND APPLICATION FOR ICF001 BY THE NMPA](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0313/2026031301573.pdf)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2652 on TradingView](https://www.tradingview.com/symbols/HKEX-2652/).

## Listing details

CF PharmTech, Inc. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2652, recorded under China. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: CF PharmTech, Inc.

- **Ticker**: 2652

- **Listing**: HKEX

- **Country or territory**: China

- **Business scope**: Pharmaceuticals: Major

- **ISIN**: CNE1000074R9

- **Last quote in directory**: 2026-10-22

- **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2652/)

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/cf-pharmtech/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "CF PharmTech (2652) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/cf-pharmtech/